The findings from this study underscore the crucial role of macrophages in the recruitment of CD8 T cells, macrophage derived Cxcl16 may represent a promising target in impeding the secondary peak inflammation mediated by T cells in the chronic stage of AKI. Here, CXCL16 is linked to acute kidney injury.